fluorodeoxyglucose f18 has been researched along with Tachycardia, Ventricular in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 13 (52.00) | 24.3611 |
2020's | 12 (48.00) | 2.80 |
Authors | Studies |
---|---|
Appelbaum, J; Bhan, A; Bogun, FM; Chicos, AB; Crawford, TC; Dickfeld, T; Eagle, KA; Ellenbogen, KA; Froehlich, J; Hoogendoorn, JC; Kapa, S; Kim, HM; Kron, J; Mankad, P; Marchlinski, FE; Murgatroyd, F; Muser, D; Narasimhan, C; Patton, KK; Robinson, MR; Rosenthal, DG; Roukoz, H; Sacher, F; Santangeli, P; Sauer, WH; Siontis, KC; Soejima, K; Vedantham, V; Zeppenfeld, K; Zipse, MM | 1 |
Fujii, S; Fukuda, M; Ishiguchi, H; Kawano, R; Kobayashi, S; Nakashima, Y; Nanno, T; Okamura, T; Suga, K; Yano, M; Yano, Y; Yoshiga, Y; Yoshitomi, R | 1 |
Griffin, JM | 1 |
de Almeida, SA; de Brito, ASX; de Oliveira, RS; de Sousa, AS; Moll-Bernardes, RJ; Rosado-de-Castro, PH | 1 |
Fujita, S; Fujiyoshi, H; Hoshiga, M; Inoue, M; Kanzaki, Y; Miyamura, M; Morimoto, T; Terasaki, F | 1 |
Alqarawi, W; Beanlands, R; Birnie, D; Celiker-Guler, E; Chakrabarti, S; de Kemp, R; Healey, JS; Hruczkowski, TW; Juneau, D; Leung, E; Medor, MC; Nery, PB; Odabashian, R; Promislow, S; Quinn, FR; Spence, S; Weng, W; Wiefels, C | 1 |
Berger, RD; Calkins, H; Chrispin, J; Derakhshan, A; Gilotra, NA; Gowani, Z; Habibi, M; Misra, S; Okada, DR; Smith, J; Tandri, H; Zimmerman, SL | 1 |
Appelbaum, DE; Carter, SV; Flatley, E; Kebed, KY; Lang, RM; Moss, JD; Patel, AR; Singh, A; Tung, R; Ward, RP | 1 |
Cai, MS; Chen, L; Gu, M; Hu, YR; Hua, W; Jing, R; Niu, HX; Sun, XX; Yang, SW; Zhang, NX; Zhang, S | 1 |
Antoine, C; Chetanneau, A; Delannoy, E; El Yaagoubi, Y; Prunier-Aesch, C | 1 |
Bentzen, SM; Chen, W; Dickfeld, TL; Dilsizian, V; Mahat, JB; Mesubi, O; Miller, B; Restrepo, A; See, V; Shorofsky, S; Smith, MF; Vunnam, R | 1 |
Abe, T; Bekki, M; Enomoto, M; Fukumoto, Y; Honda, A; Igata, S; Kaida, H; Kakuma, T; Maeda-Ogata, S; Sugiyama, Y; Tahara, A; Tahara, N | 1 |
Haarala, A; Kähönen, M; Korkola, P; Nikus, K; Sipilä, K; Tikkakoski, A; Tuominen, H | 1 |
Alavi, A; Callans, DJ; Castro, SA; Desjardins, B; Dixit, S; Enriquez, A; Garcia, FC; Hayashi, T; Liang, JJ; Magnani, S; Marchlinski, FE; Muser, D; Nucifora, G; Santangeli, P; Werner, TJ; Zado, ES | 1 |
Beanlands, RS; Birnie, DH; DaSilva, J; de Kemp, RA; Klein, R; Leung, E; Mc Ardle, BA; Nery, PB; Renaud, J; Wells, GA | 1 |
Blankstein, R; Di Carli, MF; Dorbala, S; Hainer, J; Kazemian, P; Kim, CK; Kwong, RY; Murthy, VL; Naya, M; Osborne, M; Padera, R; Skali, H; Stevenson, WG; Tokuda, M; Waller, A | 1 |
Beanlands, RS; Birnie, DH; Davis, D; Gollob, MH; Green, M; Healey, JS; Leung, E; McArdle, BA; Nair, GM; Nery, PB; Ohira, H; Yang, J | 1 |
Hänninen, H; Holmström, M; Kivistö, S; Pöyhönen, P | 1 |
Kaur, D; Lalukota, K; Narasimhan, C; Panda, S; Pavri, BB; Sundar, G | 1 |
Chowdhury, M; Farooqi, F; Honarbakhsh, S; Mcbeath, K | 1 |
Chen, W; Dickfeld, T; Dilsizian, V; Duell, J; Smith, M | 1 |
Abdulghani, M; Asoglu, R; Chen, W; Dickfeld, TM; Dilsizian, V; Ghzally, Y; Hussein, AA; Niekoop, M; See, V; Shorofsky, SR; Smith, M | 1 |
Blankstein, R; Buckley, O; Desai, A; Di Carli, M; Dorbala, S; Doyle, L; Kwong, R; Lakdawala, N; Padera, R | 1 |
Britton, KA; Katz, JT; Levy, BD; Loscalzo, J; Stevenson, WG | 1 |
Busch, M; Gawaz, M; Kettering, K; Laszlo, R; Reimold, M; Schreieck, J; Schwegler, AC; Weig, HJ | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Tachycardia, Ventricular
Article | Year |
---|---|
Nuclear Imaging Guidance for Ablation of Ventricular Arrhythmias.
Topics: Catheter Ablation; Fluorodeoxyglucose F18; Guanidines; Heart Failure; Humans; Iodine Radioisotopes; Positron-Emission Tomography; Practice Guidelines as Topic; Prognosis; Radiopharmaceuticals; Tachycardia, Ventricular; Tomography, Emission-Computed, Single-Photon | 2016 |
1 trial(s) available for fluorodeoxyglucose f18 and Tachycardia, Ventricular
Article | Year |
---|---|
Atrial Arrhythmias in Clinically Manifest Cardiac Sarcoidosis: Incidence, Burden, Predictors, and Outcomes.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomyopathies; Case-Control Studies; Cohort Studies; Cost of Illness; Defibrillators, Implantable; Female; Fluorodeoxyglucose F18; Heart Atria; Humans; Immunosuppression Therapy; Incidence; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Sarcoidosis; Tachycardia, Ventricular | 2020 |
23 other study(ies) available for fluorodeoxyglucose f18 and Tachycardia, Ventricular
Article | Year |
---|---|
Outcomes Associated With Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis.
Topics: Adult; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Death, Sudden, Cardiac; Defibrillators, Implantable; Electric Countershock; Female; Fluorodeoxyglucose F18; Heart; Heart Transplantation; Humans; Inflammation; Male; Middle Aged; Mortality; Multivariate Analysis; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Sarcoidosis; Stroke Volume; Tachycardia, Ventricular; Treatment Outcome | 2022 |
Enhanced oxidative stress and presence of ventricular aneurysm for risk prediction in cardiac sarcoidosis.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Biomarkers; Cardiomyopathies; Death, Sudden, Cardiac; Fluorodeoxyglucose F18; Heart Aneurysm; Humans; Myocarditis; Oxidative Stress; Prospective Studies; Risk Factors; Sarcoidosis; Tachycardia, Ventricular | 2022 |
Sex differences in cardiac sarcoidosis.
Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Myocarditis; Positron-Emission Tomography; Sarcoidosis; Sex Characteristics; Tachycardia, Ventricular | 2023 |
Can PET/CT be useful in predicting ventricular arrhythmias in Chagas Disease?
Topics: Aged; Arrhythmias, Cardiac; Chagas Disease; Fibrosis; Fluorodeoxyglucose F18; Gadolinium; Humans; Inflammation; Male; Myocardium; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Risk Assessment; Tachycardia, Ventricular; Technetium Tc 99m Sestamibi; Ventricular Dysfunction | 2020 |
A Patient with Cardiac Sarcoidosis in Whom an Abnormal Myocardial Uptake of Fluorine-18 Fluorodeoxyglucose and Sustained Ventricular Tachycardia Recurred 3.5 Years after Discontinuing Oral Corticosteroid Therapy.
Topics: Adrenal Cortex Hormones; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Sarcoidosis; Tachycardia, Ventricular | 2020 |
Utility of Cardiac Magnetic Resonance Imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis.
Topics: Adult; Aged; Cardiomyopathies; Death, Sudden, Cardiac; Defibrillators, Implantable; Electric Countershock; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Risk Assessment; Sarcoidosis; Tachycardia, Ventricular; Ventricular Fibrillation | 2020 |
Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
Topics: Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Tachycardia, Ventricular | 2021 |
Global and regional cardiac dysfunction quantified by
Topics: Adult; Aged; Cardiac Imaging Techniques; Defibrillators, Implantable; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Tachycardia, Ventricular; Tomography, Emission-Computed, Single-Photon; Ventricular Fibrillation; Ventricular Function, Left | 2021 |
Diffuse 18F-FDG PET/CT Uptake of the Bilateral Atrial Walls in Atrioventricular Nodal Re-entrant Tachycardia.
Topics: Aged, 80 and over; Biological Transport; Diagnosis, Differential; Electrocardiography; Fluorodeoxyglucose F18; Heart Atria; Humans; Male; Positron Emission Tomography Computed Tomography; Tachycardia, Ventricular | 2021 |
Metabolic heterogeneous zone assessed by
Topics: Aged; Cicatrix; Fluorodeoxyglucose F18; Humans; Middle Aged; Myocardium; Positron-Emission Tomography; Tachycardia, Ventricular | 2021 |
Localization of myocardial FDG uptake for prognostic risk stratification in corticosteroid-naïve cardiac sarcoidosis.
Topics: Adrenal Cortex Hormones; Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocarditis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Assessment; Sarcoidosis; Tachycardia, Ventricular; Tomography, X-Ray Computed | 2022 |
Topics: Adult; Atrioventricular Block; Coronary Angiography; Coronary Artery Disease; Female; Finland; Fluorodeoxyglucose F18; Heart; Heart Ventricles; Humans; Inflammation; Male; Middle Aged; Myocardium; Observer Variation; Positron-Emission Tomography; Prevalence; Retrospective Studies; Sarcoidosis; Sex Factors; Tachycardia, Ventricular | 2019 |
Prognostic role of serial quantitative evaluation of
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardium; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoidosis; Tachycardia, Ventricular | 2018 |
Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography?
Topics: Adult; Aged; Area Under Curve; Atrioventricular Block; Cardiomyopathies; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Perfusion Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Registries; ROC Curve; Sarcoidosis; Stroke Volume; Tachycardia, Ventricular; Tomography, X-Ray Computed; Ventricular Function, Left | 2013 |
Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
Topics: Cardiomyopathies; Coronary Circulation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Perfusion Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rubidium Radioisotopes; Sarcoidosis; Stroke Volume; Tachycardia, Ventricular | 2014 |
Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Atrioventricular Block; Biopsy; Cardiomyopathies; Defibrillators, Implantable; Disease-Free Survival; Electric Countershock; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Immunosuppressive Agents; Male; Middle Aged; Ontario; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Prospective Studies; Radiopharmaceuticals; Recurrence; Risk Factors; Sarcoidosis; Tachycardia, Ventricular; Time Factors; Tomography, X-Ray Computed; Young Adult | 2014 |
Late gadolinium enhancement on CMR and sustained ventricular tachycardia predict severe cardiac inflammation.
Topics: Adult; Biopsy; Cardiomyopathies; Contrast Media; Echocardiography; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tachycardia, Ventricular; Tomography, Emission-Computed, Single-Photon | 2014 |
Pleomorphism during Ventricular Tachycardia: A Distinguishing Feature between Cardiac Sarcoidosis and Idiopathic VT.
Topics: Adult; Cardiomyopathies; Contrast Media; Diagnosis, Differential; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Tachycardia, Ventricular; Tomography, X-Ray Computed | 2015 |
Undiagnosed cardiac sarcoidosis presenting as complete heart block and ventricular arrhythmia.
Topics: Cardiomyopathies; Defibrillators, Implantable; Fluorodeoxyglucose F18; Heart Block; Humans; Male; Middle Aged; Positron-Emission Tomography; Sarcoidosis; Tachycardia, Ventricular | 2015 |
Hibernating substrate of ventricular tachycardia: a three-dimensional metabolic and electro-anatomic assessment.
Topics: Aged; Body Surface Potential Mapping; Female; Fluorodeoxyglucose F18; Heart Conduction System; Humans; Imaging, Three-Dimensional; Male; Myocardial Stunning; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tachycardia, Ventricular | 2017 |
Cardiomyopathy of uncertain etiology: Complementary role of multimodality imaging with cardiac MRI and 18FDG PET.
Topics: Arrhythmias, Cardiac; Cardiomyopathies; Coronary Angiography; Coronary Artery Disease; Echocardiography; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Syncope; Tachycardia, Ventricular; Ventricular Dysfunction, Left | 2010 |
Clinical problem-solving. The beat goes on.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrioventricular Block; Biopsy; Cardiomyopathies; Diagnosis, Differential; Echocardiography; Electrocardiography; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Male; Middle Aged; Myocardium; Prednisone; Sarcoidosis; Tachycardia, Ventricular; Ventricular Dysfunction, Right | 2010 |
Catheter ablation of ventricular tachycardias in patients with ischemic cardiomyopathy: validation of voltage mapping criteria for substrate modification by myocardial viability assessment using FDG PET.
Topics: Aged; Body Surface Potential Mapping; Catheter Ablation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Myocardial Ischemia; Positron-Emission Tomography; Radiopharmaceuticals; Tachycardia, Ventricular; Treatment Outcome | 2010 |